Several mechanisms might explain possible benefits: Improved glycaemic control : Better blood glucose regulation may reduce endothelial dysfunction and microvascular damage, both implicated in ED pathophysiology Weight reduction : Significant weight loss can improve testosterone levels, reduce inflammation, and enhance vascular function Cardiovascular effects : GLP-1 agents may improve endothelial function and reduce cardiovascular risk factors that contribute to ED Reduced inflammation : These medications have been associated with anti-inflammatory effects that might benefit vascular health, though more research is needed Some observational studies have reported improvements in erectile function scores among men with diabetes treated with GLP-1 receptor agonists, though the evidence is limited and more robust research is needed
It's classified as a non-FDA-approved compounded preparation, which federal and state plans categorically exclude
719.867.5389 Drugs like semaglutide (also known as GLP-1s, or glucagon-like peptide-1 receptor agonists) have revolutionized the treatment of type 2 diabetes and obesity over the last few years
Result Snapshot: Patients typically see 12% to 15% weight reduction
It represents a new generation of investigational peptides designed to simulate natural hormonal responses involved in glucose metabolism, appetite suppression, and energy balance
This process requires attention to detail but becomes routine with practice
